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Sumnlagy 
Dendritic cells (DC) are widely distributed in the lung where they are distinguished by their 
morphology and class II major histocompatibility complex (Ia) antigen expression. Although 
a role for DC as pulmonary antigen-presenting cell (APC) has been suggested, little is currently 
known concerning how these ceils respond to inhaled antigens in vivo. Hen-egg lysozyme (HEL) 
was injected intratracheally into Lewis rats; DC were subsequently purified from the lung and 
regional lymph nodes (LN) at intervals of up to 14 d and examined for their ability to stimulate 
the proliferation of HEL-immune T calls in vitro in the absence of added HEL. Pulmonary DC 
displayed APC activities at 3 h and for up to 7 d after the injection of antigen. Dendritic cells 
in the draining hilar LN showed APC activities that appeared at 24 h, peaked at day 3,  and 
then diminished progressively. After the primary sensitization, HEL-immune T  ceils were de- 
tected in hilar LN but not in the lung. A second airway challenge with HEL at day 14 yielded 
an antigen-specific pulmonary immune response, characterized histologically by the accumula- 
tion of mononuclear calls around lung venules. We conclude that APC activities shift from lung 
to lymph node during the response to inhaled antigen. 
p ulmonary immune responses can be generated by the 
introduction of antigen into the airways (1-3). The de- 
velopment of specific cell-mediated pulmonary immunity re- 
quires an afferent phase, during which inhaled antigens are 
captured, processed, and presented to T cells by class II MHC 
(Ia) + accessory cells. Until recently, it was widely believed 
that macrophages were the dominant APC in the lung. How- 
ever, pulmonary macrophages generally do not provide ac- 
cessory support for T  cell mitogen responses (4-8). 
Investigators have demonstrated that Ia + dendritic mono- 
nuclear cells are the effective APC of the lung (9-14). These 
cells are strategically located in the pulmonary airways, pul- 
monary vessds, alveolar septa,  and pleura, where they may 
function as sentinds for inhaled or circulating antigens. Holt 
et al. (11) have shown that pulmonary dendritic cells (DC) 1 
can present inhaled antigens to immune T calls and that they 
traffic from the lung to the draining LN, after exposure to 
an airway bacterial stimulus (15).  In the present study, we 
examined changes in the APC activities of DC in the lung 
and draining LN after an intratracheal challenge with hen- 
egg lysozymes (HEL). 
1  Abbreviations used in this  paper: DC, dendritic cells; HEL, hen-egg lyso- 
zyme; i.t., intratracheally. 
Materials and Methods 
Animals 
Inbred, pathogen-free, 6-8-wk-old female  Lewis rats (150-250 g) 
were obtained from Charles River Laboratories (Kingston, MA). 
Rats were housed in a restricted access animal care facility, and per- 
mitred access to food and water ad libitum. 
Reagents and Antibodies 
HEL.  HEL (Sigma Chemical Co., St. Louis, MO) was pre- 
pared at a concentration  of 1 mg/ml in normal saline, filtered 
through a 0.45-#m low protein-binding filter (Acrodisc no. 4184; 
Fisher Scientific, Boston, MA) and stored at 4~ 
Heat-killed Listeria monocytogenes (HKL).  HKL was obtained 
from the M.G.H.  Bacteriology Laboratory (Boston, MA). The 
concentration of organisms was determined by McFarland Nephe- 
lometer standards and the bacteria were heat-inactivated in a 63~ 
water bath for 90 min. Viability was assessed  by the failure of the 
bacteria to grow on blood agar plates. Aliquots (109 bacteria/m1 
in saline) were stored at  -20~ 
Indocyanine Green.  Indocyanine green dye (2.5 mg/ml; Becton 
Dickinson Microbiology Systems, Mountain View, CA) was used 
as a marker for the distribution of HEL in the lung after intratracheal 
administration. 
Chloral Hydrate.  Chloral  hydrate (Fisher Scientific) was ad- 
ministered as an anesthetic at a dose of 400 mg/kg. 
Collagenase.  CoUagenase (150 U/ml; Worthington Biochem- 
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Co.) were freshly prepared for digestion of rat lung. 
BSA.  BSA was prepared by a modification of the procedure 
of Steinman and Colin (16). 10.5 g BSA powder, fraction V (In- 
tergen, Purchase, NY), was solubilized in 2.9 ml 1 N NaOH, 5.8 
ml double distilled  water,  and 18.6 ml PBS to yield a final pH of 
7.35  _+ 0.05 and a density of 1.080, as judged by density refrac- 
tometry (ABBE-3L, 33-46-10; VWR Sdentific, Boston, MA). The 
solution was filtered using a 0.45-gin filter with prefilter (Nalgene; 
Fisher Sdentific) and maintained at 4~  before use. 
Complete Medium (CM) and Culture Conditions.  Calls were cul- 
tured in KPMI-1640 (JKH Biosciences, Lenexa, KS), 10% heat- 
inactivated fetal bovine serum (FBS; Sigma Chemical Co.), 50 t~g/ml 
Gentamycin (GIBCO BILL, Gaithersburg, MD), 0.5% 1 M Hepes 
buffer (GIBCO  BILL),  and  2-mercaptoethanol (5  x  10 -s  M) 
(Sigma  Chemical Co.),  and incubated at 37~  in a humidified 
chamber of 95%  air and 5%  COs. 
FHlThymidin~  padiolabel was used at 1 #Ci/well (specific ac- 
tivity 81.0 Ci/mmol; Dupont/New England Nuclear, Boston, MA). 
rh-IL2,  rhIL-2 (Cetus Corp., Emeryvilh, CA) was  added  to 
culture wells at a final concentration of 100 U/nil. 
Monodonal Mouse Anti-rat Antibodies.  Anti-rat mAbs were used 
to purify and characterize cells in these studies.  These included: 
W3/13 (CD43), W3/25 (CD4), OX-8 (CDS), OX-39 (CD25), 
OX-1 (CD45K), OX-22 (CD45KC), OX-43, OX-6 (Ia), (all from 
Accurate Chemical & Scientific Co., Westbury, NY); ED1 and ED2 
(a generous gift from C. Dijkstra, Free University, Amsterdam, 
the Netherlands),  anti-IgM, OX-12 (anti-r light chain), and OX-33 
(CD45KA); (all from Pharmingen, San Diego, CA). The mAbs 
were prepared either as ascites or supernatants at predetermined 
optimal concentrations. For in situ localization,  DC or lung tissues 
were  stained  by an  avidin-biotin  immunoperoxidase  technique 
(13). Surface  immune phenotype was  examined in a cytofluori- 
meter (FACS  |  440; Becton Dickinson) after direct staining with 
fluorescein-conjugated anti-rat  mAbs  or indirect staining with 
goat F(ab')2 anti-mouse IgG-FITC (Tago Immunologicals, Cama- 
rillo,  CA) (17). 
Generation of HEL and HKL Immune T Cells.  Pats were im- 
munized with an emulsion of 100 #g HEL or 107 HKL in CFA 
(Difeo Labs., Detroit, MI). The emulsion (0.1 ml) was injected 
bilaterally at the base of the tail; inguinal LN were harvested at 
10-14 d, mechanically dispersed,  and separated on Isolymph (Gal- 
lard Scklesinger Industries Inc., Carle Phce, NY). LN mononuclear 
cells (2  x  106) were incubated in 24-well culture plates with HEL 
(100 gg/ml) or HKL (107/ml) antigen in a humidified chamber of 
95% air and 5% CO2. IL-2 (100 U/m1) was added to the medium 
at day 5 and then 2-3 times weekly. Every 3-4 wk, the cultures 
were restimulated with HEL or HKL, respectively, in the presence 
of normal irradiated (3,000 cGy) syngeneic spleen cells at a ratio 
of 10:1 spleen ceils to T cell blasts. Immune phenotyping by cyto- 
fluorimetry showed the antigen-specific  lymphobhsts were >95% 
W3/25 +  (CD4) OX22- (CD45KC). The specificity of the response 
was judged by a greater than threefold difference in the magnitude 
of [3H]thymidine incorporation by T cell blasts to HEL compared 
to an irrelevant antigen (HKL). 
Intratracheal Instillation.  Pats were lightly anesthetized with 
chloral hydrate (400 gg/kg),  and the trachea was surgically ex- 
posed. Equal volumes (0.1 ml) of HEL (10 or 100 gg/rat), normal 
saline, and indocyanine green (2.5 mg/ml) were introduced into 
the trachea slowly via a 25-gauge needle. The rats were subsequently 
killed at 3 and 24 h, and at days 3, 7, and 14. In some experiments, 
rats were rechallenged with HEL (100 #g/rat) intratracheally on 
day 14 and killed at 72 h, to determine whether HEI~spedfic T cell 
responses  were generated in the lung. 
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Dendritic Cell Purification.  Dendritic cells were purified from 
lung, spleen,  hilar LN, and inguinal LN, as previously described 
(13). Briefly, lungs were perfumed with saline via the pulmonary 
artery to diminish blood contaminants.  Excised lung tissue  was 
digested with cofiagenase and DNase, fractionated by BSA density 
gradient sedimentation, and the desired mononuclear cell fraction 
was  attached  to  tissue  culture dishes  (no.  3003/Falcon;  Fisher 
Scientific) with CM for 2 h at 37~  Nonadherent calls were dis- 
carded and the adherent fraction was cultured overnight at 37~ 
Loosely adherent cells enriched for DC were further subjected  to 
immunopanning with OX-6. The selected ceils were retrieved by 
gentle scraping with a rubber policeman and applied to plastic tissue 
culture dishes for 1 h at 37~  to remove adherent macrophages. 
The nonadherent ceils were  judged to be highly enriched (>90%) 
for DC based on their morphology, failure to stain for nonspecific 
esterase, immunostaining characteristics,  and ability to stimulate 
a primary allogeneic  MLK (13). 
Accessory Cell Activities.  Dendritic cells from the lung and LN 
were irradiated (3,000 cGy), suspended  in CM,  and plated (10  4 
cells/well)  into 96-well fiat-bottom culture plates (Falcon; Fisher 
Scientific).  Nylon wool-treated and OX-6 + ceil-depleted  splenic 
lymphocytes, HEL-immune, or HKL-immune T  cells (5  x  10  ~) 
were added to DC with or without HEL (100 gg/ml) or HKL 
(107 bacteria/ml). The culture plates were incubated for 72 h at 
37~  and the wells were pulsed with [3H]thymidine (1 t~Ci/weH) 
for 6 h before harvesting. The pulsed wells were harvested in a 
semi-antomatic  cell  harvester (Skatron  Inc.,  Sterling,  VA)  and 
counted in a Tri-Carb liquid t-scintillation spectrometer (Packard 
Instrument Co., Sterling, VA). The percent specific response was 
calculated  by the formula: 
cpm  (HEL immune T cells +  HEL pulsed DC)  _ 
(HEL immune T cells +  HEL pulsed DC  +  HEL) 
cpm  (HEL immune T cells +  control DC)  x  100 
(HEL immune T cells +  control DC  +  HEL) 
Limiting Dilution Analysis (LDA).  The frequency of DC func- 
tioning as APC in vivo was estimated by LDA. I-IEbimmune T cells 
(5  x  104/we11) were plated in >20 replicate wells of 96-wall fiat- 
bottom culture plates  with irradiated DC (9.75-1250/well) iso- 
hted from HELchallenged lung~ The phtes were incubated at 37~ 
for 72 h and the wells were pulsed with [3H]thymidine (1/zCi/ 
well) for 6 h before harvesting. A positive response was scored when 
the mean cpm per well e~,,ceeded the mean cpm  +  3  x  SD of 
[3H]thymidine incorporation of wells that received antigen-specific 
T ceils alone.  When the number of DC providing APC activity 
is limiting,  a positive response (Fo) is  not detected.  The mean 
number of  limiting ceils, designated g, was estimated by the Poisson 
distribution. Wells showing no response were scored, and the frac- 
tion of nonresponding wells was plotted against  cell number for 
each condition. As estimates of g are most accurate in the range, 
0.1 <  Fo <  0.37, the limiting number of DC was estimated for 
F  ~  0.37. 
Results 
Dendritic Cell Yield and Purity.  Visual inspection of the 
freshly excised lungs showed that the intratracheal instillates 
were well distributed,  as judged by the bilateral discolora- 
tion of pulmonary parenchyma by the indocyanine green dye 
(Fig. 1). The immune phenotype of the putative pulmonary 
DC fraction was assessed by staining the cells in suspension 
with a pand of mAbs followed by cytofluorimetry or by anal- 
Lung Dendritic Cells Present Inhaled Antigen In Vivo Figure l.  Distribution  of  HEL after intratracheal instillation. The lung 
parenchyma shows diffuse bilateral green discoloration due to the distri- 
bution of indocyanine green in the instillate. 
)'sis of immunostained cytocentrifuge preparations. Table 1 
shows that virtually all of the cells were CD45R +  , consis- 
tent with their origin in the bone marrow. Approximately 
95% were OX-6 + but <5% stained for T cell (CD4, CDS) 
or B cell (CD45RA, slgM, K  light chain) markers. Less than 
10% of the putative DC population stained for either ED1 
or ED2 antigens, that are expressed by pulmonary macro- 
phages (18). 
The primary instillation of HEL i.t. did not yield a sub- 
stantial difference in the number of pulmonary DC at 48 h 
compared to saline controls (1.4  _+ 0.5 vs. 1.6  +_ 0.5  x  10  s 
cells/g wet lung).  However, the secondary challenge with 
HEL at day 14, resulted in a sixfold increase ~  =  0.01)  in 
the number of  pulmonary DC at 72 h compared to the saline 
control (Fig.  2). 
Purified DC and unfractionated pulmonary mononuclear 
cells from the lung digests were compared for their ability to 
serve as APC. Pulmonary DC were substantially more effec- 
tive than the unfractionated lung cells in supporting [3H]thy- 
midine incorporation by HELimmune T  cells  (Fig.  3). 
APC Activities of  An#'gen-pulsed  Pulmonary DC.  Next, pul- 
monary DC purified from the HEbchallenged rats were ex- 
amined for their ability to specifically promote [3H]thymi- 
dine incorporation in vitro by (a) HEbimmune T  cells, (b) 
HKbimmune T cells, and (c) nonimmune spleen cells in the 
absence of added HEL. At 3 h after the intratracheal adminis- 
tration of HEL (100/~g/ml), pulmonary DC yielded a 92- 
fold increase in the response of HEL-immune T cells, but did 
not stimulate HKbimmune T  cells  or nonimmune spleen 
cells. The level of the specific response seen at 3 h was com- 
parable to that achieved when control pulmonary DC were 
incubated with both HEbimmune  T  cells  and HEL  (100 
/zg/ml)  (Table  2). 
Having established the specificity of the APC response, 
we examined its kinetics in vivo. After a single intratracheal 
challenge with HEL (100 ~g/rat), pulmonary DC were able 
to present antigen for up 7 d  (Fig.  4).  The magnitude of 
the response varied directly with the dose of HEL (10-100 
/~g/rat)  administered i.t.  (Fig.  5).  When  the  lungs  were 
rechallenged with HEL i.t.  at day 14, a second peak in the 
specific APC  activities of pulmonary DC was observed at 
72  h  (Fig.  4). 
LDA of  DC Activity.  LDA, established 24 h after the HEL 
intratracheal challenge, showed that  ~102 in vivo antigen- 
pulsed pulmonary DC  were able  to  generate a  detectable 
mitogen response. A similar level of response was observed 
Table 1.  Surface Immune Phenotype of Pulmonary DC 
Percent positive 
Surface antigen  staining 
CD45K (OX-1)  99  _+ 5 
Class II MHC (OX-6)  95  _+ 4 
CD45KC  (OX-22)  4  +_  1 
CD4 (W3/25)  2  _+  2 
CD8 (OX-8)  I  _+ 0.2 
slgM  2  _+  1 
CD45RA  (OX-33)  4  _+  1 
K light chain (OX-12)  3  _+  1 
ED1  5  +_  2 
ED2  9  +_ 3 
0.S ￿9 
0.4 
0.3 
0.2 
0.1 
0.0 
CONTROL  POST- HEI..  CHALLENGE 
Pulmonary DC  were  stained  with  anti-rat  mAbs  and  analyzed  by 
cytoftuorimetry  or by immunoperoxidase  staining. The vast majority of 
cells were la + and hcked markers ofT cell, B cell, or macrophage line- 
age. Data are the mean  •  SD of three experiments. 
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Figure 2.  Pulmonary DC increase after a repeat intratracheal antigen 
challenge  in previously  sensitized  rats. Rats sensitized  with HEld (100  tzg/rat) 
i.t. were rechalhnged on day 14. There was a significant increase (p  = 
0.1) in the number of pulmonary DC purified from the lung digests at 
48 h. Data are the mean  •  SD of three  experiments. 200 ]  80 - 
i  150  ~  60 
=~ 
'  :t  ~ 
2o 
0  12 
0  CELL  NUMBER  (I0-3) 
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Figure  3.  Differences  in antigen presentation by purified lung DC and 
bulk lung digest cells. HEL-immune T cells were cultured with HEL (100 
/~g/ml) and either purified lung DC or unfractionated mononuclear cells 
from the pulmonary digests (103-104) for 72 h. The cultures were pulsed 
with [3H]thymidine (1/~Ci/well)  for 6 h, harvested, and counted in a 
B-spectrometer. O, Lung DC; O, lung mononuclear cells. 
when  LDA was repeated  for DC  harvested  at day 3  (data 
not  shown). 
APC Activity of DC from Hilar LN.  In parallel,  we ex- 
amined the APC activities of DC purified from the draining 
hilar LN after the HEL intratracheal challenge. Dendritic cells 
from the LN did not stimulate a specific T  cell response by 
HEL-immune cells at 3  h.  However,  APC activity was de- 
tected at 24 h, peaked at day 3,  and then gradually dimin- 
ished to control levels by day 14  (Fig.  4).  When  sensitized 
rats were rechallenged i.t. with HEL and examined at 72 h, 
a second rise in APC activities was observed (Fig.  4). After 
intratracheal injection of HEL, DC harvested from inguinal 
LN (Table 3) or spleen (not shown) did not elicit a mitogen 
response unless HEL was added directly to the culture wells. 
DAYS  FOLLOWING  HEL  I.T.  INSTILLATION 
Figure 4.  The kinetics ofDC-associated APC activities after an airway 
challenge with HEL. Dendritic calls were purified from the lung and 
draining hilar LN at intervals after an airway challenge with HEL. DC 
from the lung showed peak APC activity at 3 h, which subsequently de- 
creased gradually to day 7. APC activity in the LN peaked at day 3 and 
was detectable until day 14. When rats received a second challenge with 
HEL i.t., specific  DC-associated APC responses were again stimulated in 
lung and LN.  O, Lung DC;  e, LN DC. 
Immune Phenotype of  Pulmonary T Cells In Viva  Lympho- 
cytes isolated from the lungs were examined for their surface 
immune phenotype. Table 4 shows that pulmonary lympho- 
cytes from saline controls  displayed a  slight  dominance  of 
CD4 + cells and few expressed the OX-39 antigen  (Ib2R). 
The primary HEL challenge yielded a small decrease in the 
percentage  of  CD4 +  pulmonary  lymphocytes  and  little 
change in Ib2R + lymphocytes. The secondary challenge at 
day 14 increased the percentage of pulmonary CD4 + lym- 
phocytes but also did not increase the percentage of IL-2R + 
lymphocytes. 
Less than  5%  of CD4 +  cells  in  the  lung  expressed  the 
Table 2.  Antigen Presentation by HEL-pulsed Pulmonary DC 
Additions  to  Proliferation 
Responding  cells  culture wells  HEL-pulsed DC  Saline-control DC  index 
cpm  x  I0 -3  +  SD 
HEL-immune T  cells  None  275  _+  50  3  +  1  92 
HEL  309  _+  53  194  _+  24 
HKL  226  •  18  3  _+  1 
HKL-immune T  cells  None  2  +  1  3  +  1  0.7 
HEL  1  +  1  2  +  1 
HKL  295  +  25  235  +  20 
Nonimmune  splenic  T  cells  None  8  +  3  14  +  2  0.6 
HEL  6  +  1  16  +  1 
HEL-pulsed DC isolated from the lung 3 h after the i.t. injection of HEL (100 #g/rat) i.t. were able to support the specific proliferation of HEL- 
immune T cells but not HKL-immune or non-immune splenic T cells in a 72 h proliferation assay. HEL-immune T cells did not respond to saline 
injected control DC unless HEL antigen (100/*g/ml)  was added to the culture wells. Data is mean _+ SD of one of three representative experiments. 
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Hgntl~  5.  The APC activities of pulmonary DC after intratracheal chal- 
lenge with HEL are dose dependent.  Pulmonary DC from rats receiving 
HEL (100 #*g/rat) showed greater  specific APC activities at day 3 and 5 
(both p < 0.01) compared  to DC from rats that received a lower dose of 
HEL (10 ~g/rat) or saline. Data are the mean :t: SD of three experiments. 
O, Saline; O, HEL (10 ~g/rat); A, HEL (100 #g/rat). 
OX-22 (CD45RC) isoform of the common leukocyte antigen, 
whereas 97% of pulmonary CD8 + cells were OX-22 + . As 
naive and sensitized T cells may display distinct pathways of 
lymphocyte circulation in vivo (19), we examined whether 
the expression of OX-22 was modulated on naive spleen cells 
by the polyclonal T cell activator Con A (5 #g/ml). At 72 h, 
93% of W3/25 lymphocytes were OX-22-, whereas virtu- 
ally all OX-8 + cells were OX-22 + , suggesting that there is 
a major difference in how class I (CD8 +) and II (CD4 +) 
MHC-restricted T cell subsets regulate their OX-22 expression. 
Table 3.  Antigen Presentation after Intratracheal HEL Injection 
Days  after  Addition  to  Hilar  Inguinal 
HEL i.t.  culture  wells  LN-DC  LN-DC 
CPM 10 -3  +  SD 
3  None  33  +  3  1  _+  0.05 
7  None  18  _+  5  0.8  _+  0.01 
14  None  4  +  0.3  0.4  _+  0.02 
3  HEL  70_+  10  62  +  3 
7  HEL  70  +  7  69  _+  4 
14  HEL  66  _+  5  55  _+  3 
Dendritic cells from hilar  and inguinal  LN were isolated on days 3, 7, 
and  14 after  the introduction of HEL (100 t~g/rat)  i.t., cultured with 
HEL-immune T cells  +  HEL (100/~g/ml) for 72 h, and examined  for 
[3H]thymidine  incorporation after a 6-h pulse.  Inguinal LN-DC show 
no capacity to support  the mitogen response of HEL-immune blasts in 
the absence of added  HEL. 
Table 4.  Immune Phenot),pe of Pulmonary Lymphocytes 
Surface antigen percent  positive  +  SD 
CD4/CD8 
Condition  CD4  CD8  IL-2R  ratio 
Control  40  +_  13  31  _+  6  5  _+  1  1.2 
Post-HEL  1 ~ 
challenge  34  +  8  32  +_  9  6  _+  2  1.1 
Post-HEL  2 ~ 
challenge 
(day  17)  39  +  4  28  +  8  9  _+  4  1.7 
Lymphocytes harvested from enzymatic digests of lung were treated with 
appropriate mAbs, stained with goat anti-mouse F(ab)'2 IgG-FITC, and 
analyzed in a FACS  ~  440 cytofluorimeter.  Data are the mean  _+  SD of 
at least three experiments. 
Immune Specificity.  To assess whether the responses in the 
lung and LN were antigen specific, T cells were purified from 
the lungs or hilar LN of HEL-challenged animals, incubated 
with irradiated syngeneic spleen APC  _+  HEL, and exam- 
ined for [3H]thymidine uptake at 72 h. After the primary 
challenge with HEL, positive responses, as judged by a stim- 
ulation index of >15 compared to the saline control, peaked 
in the draining LN at day 3 and subsequently rapidly declined. 
Antigen-specific responses were not detected in the lung be- 
fore day 14. However, when the sensitized rats were rechal- 
lenged with HEL intratracheally, lymphocytes harvested from 
both lung and LN at 72 h showed positive responses (Fig. 6). 
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DAYS FOLLOWING HEL INJECTION 
Figure 6.  T  cell responses to HEL from rats injected with HEL in- 
tratracheally. Rats received HEL (100/~g/rat)  i.t. on day 0 and again on 
day 14. Nylon wool separated lymphocytes  from lung and LN were in- 
cubated with HEL (100/*g/ml) and irradiated  splenic accessory cells at 
each time point for 72 h. Data represent the stimulation index of one of 
two experiments conducted  at each time point. O, Lung T cells; O, LN 
T  cells. 
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14 after  airway  sensitization  produces  a perivenular  lym- 
phoid infiltrate in the lung. 72 h after the repeat chal- 
lenge with HEL (100/~g/rat) i.t.  on day 14; (A) a 
perivenular (arrows) and modest interstitial lympho- 
cytic infiltrate (arrowhead) was seen in the lung; (B) 
the lung of an HEIcsensitized  rat challenged  with sa- 
line i.t. shows no accumulation  of immune cells. Im- 
munohistology showed that the majority of the lym- 
phocytes in the perivascular cuffs were CD4 § (not 
shown),  x  150. Hematoxylin and Eosin. 
Microscopic examination  of the lungs  after the primary 
challenge with HEL revealed a small increase in pulmonary 
macrophages compared to saline controls. 72 h  after the sec- 
ondary HEL intratracheal challenge, a cuff of mononuclear 
cells was seen surrounding small pulmonary veins (Fig.  7). 
Immunohistology showed that the majority of lymphocytes 
in  the  perivenular  infiltrates  were  W3/25+(CD4)  (not 
shown). Minimal inflammation of large or smaU airways was 
observed. 
Discussion 
Holt et al.  (11) have previously reported that pulmonary 
DC  exposed  to  aerosolized  OVA  in  vivo  present  antigen 
specifically to OVA-immune T  cells in vitro.  We examined 
the sequential changes in the APC  activities of pulmonary 
and  hilar  LN DC  after  an intratracheal  antigen  challenge. 
Pulmonary DC were able to present HEL shortly after it 
was introduced into the airways. These APC activities were 
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tigen in vivo selectively  stimulated a response by HEL-immune 
T cells but were unable to promote the proliferation  of ei- 
ther naive syngeneic spleen T cells or HKL-immune T cells. 
The APC activities of pulmonary DC were detected for up 
to 7 d, suggesting that antigen had been retained in vivo over 
that interval. Although, we did not directly demonstrate that 
HEL was stably associated with a population of pulmonary 
DC, the short half-life of inhaled soluble antigens in vivo 
(20-22)  makes it unlikely that free HEL was taken up by 
a renewable population of DC. Nevertheless, the possibility 
that pulmonary DC can effectivdy present antigen in the lung 
for prolonged intervals must be interpreted with caution, as 
Holt et al. have demonstrated that the half-life  of  DC in airways 
is relatively brief (23) and that the APC activities of DC are 
downregulated by pulmonary macrophages in vivo (25). 
The remarkable antigen presenting capacities of pulmo- 
nary DC in vivo were underscored by the results of the LDA, 
which  showed  that  as  few as  100  pulmonary DC  were 
sufficient to yield a specific  mitogen response after HEL chal- 
lenge. This may explain how DC function as the dominant 
APC in the lung, despite the fact that they constitute <1% 
of  pulmonary mononuclear cells (11-13). The comparable  levels 
of APC activity yielded at 24 h and day 3 in the LDA further 
suggests that the HEL antigen was not substantially catabo- 
lized over that interval in vivo. 
The present study supports the position that primary sen- 
sitization of naive T cells after an airway antigen challenge 
occurs predominantly,  if not exclusively, within local LN, 
and not in the lung or bronchial-associated lymphoid tissues 
(25, 26). The APC activities of DC in the hilar LN were 
peaking at the same time that they were decreasing in the 
lung. This suggests that migration of antigen-pulsed  pul- 
monary DC to local LN may contribute to the delivery of 
intrapulmonary antigens. In recent reports, Havenith et al. 
demonstrated that antigen-pulsed DC introduced directly into 
the airways migrate to the local LN (27) and sensitize naive 
T ceils for a subsequent specific immune response (28). The 
possibility that pulmonary DC traffic to LN after an inflam- 
matory airway  challenge  has  recently been  suggested  by 
McWilliam et al. (15). The shifts in APC activities from lung 
to LN, parallels the sequence of changes reported for den- 
dritic ceils in the skin after contact sensitization  (29). 
Gong et al. (30) have recently  reported that approximately 
half of the DC obtained by microdissection of the airways 
were FcR + and that airway DC were more efficient APC 
for sensitized T cells than DC in the lung parenchyma. They 
further demonstrated that ,,095% of DC in the lung were 
FcR-  and phenotypically resembled connective tissue DC 
(30). In a separate study from the same laboratory,  it was 
concluded that there was little difference in the APC activi- 
ties of purified FcR +_ DC subsets in the lung with respect 
their abilities to stimulate  sensitized T cells (31). The DC 
examined in the current studies were a heterogeneous popu- 
lation of FcR  _+  DC (31) that presumably reflect contribu- 
tions from DC in the intraparenchymal airways and lung pa- 
renchyma. 
The procedures used to isolate pulmonary DC are lengthy 
and may have affected the apparent APC activities observed 
in vitro. For example, the ability of lung DC to stimulate 
an MLR, a function primarily mediated by FcR- DC (31), 
increases substantially with overnight culture (32). It is rec- 
ognized that FcR + Langerhans cells differentiate into FcR- 
cells in the presence of GM-CSF (33) and that lung DC func- 
tion can mature in the presence of TNF-c~ that is produced 
by lung cells during the purification  process (32). 
The current study does not distinguish whether all, or a 
subset, of pulmonary DC, actually mediate the afferent im- 
mune response to inhaled antigen in vivo. Based on their sub- 
stantial phenotypic similarities with Langerhans cells in the 
epidermis, we speculate that the FcR + DC in the pulmo- 
nary airway epithelium may be primarily concerned with the 
transport and presentation  of antigen to the draining LN 
during the afferent response to inhaled antigen,  whereas a 
functionally mature subset  of FcR-  DC, localized in the 
connective tissues around pulmonary vessels and other sites 
in the lung, may be primarily responsible for amplifying the 
efferent immune response. 
Compartmental shifts of T lymphocytes after an airway 
challenge with antigen are likely to contribute to how the 
pulmonary cellular immune response is integrated. The T cells 
isolated from the lung before the secondary antigen challenge 
did not respond to HEL in vitro,  which suggests that the 
numerical frequency of antigen-specific T cells in the lung 
was low. However, after the secondary airway antigen chal- 
lenge at day 14, relatively weak but specific T cell responses 
were detected in the lung, associated with the accumulation 
of perivenular T lymphocytes. The localization of predomi- 
nantly CD4 + T cells around postcapillary venules is reminis- 
cent of the histologic response seen in cutaneous delayed type 
hypersensitivity  (34). 
The vast majority of lung T cells do not express the high 
molecular weight isoforms of CD45R but do show neoex- 
pression of the low molecular weight CD45R0 isoform (35). 
As loss of high molecular weight isoforms of CD45R is as- 
sociated with the acquisition of T cell "memory;' we have 
previously speculated that immunologically  naive T cells may 
be selectively  excluded from the lung (35). Compared to LN, 
which contained substantial  numbers of CD4 +  OX-22 + 
lymphocytes, virtually all CD4 + lymphocytes in both the 
control and HEIcsensitized  rat lung were OX-22-,  sug- 
gesting that these pulmonary lymphocytes had undergone 
sensitization  and compartmentalization in vivo. 
Based on these findings, we suggest the following path- 
ways in the generation of a pulmonary cell-mediated response 
to airway antigen. After the inhalation of antigen, we specu- 
late that a subset  of FcR+DC in the airways entraps  the 
antigen, transports  it to the draining LN, and presents it 
to naive T  cells, in a scenario that is comparable to how 
Langerhans cells function in the skin  (36). Subsequently, 
sensitized T  cells leave the draining LN and enter the cir- 
culation.  The virtual  exclusion of OX-22 + "naive" CD4 + 
T cells from the lung coupled with rapid clearance of inhaled 
antigen effectively  assures that a pulmonary immune response 
1281  Xia et al. will not  occur  after a  primary airway antigen challenge. 
However, after a secondary challenge lymphocytes are rap- 
idly recruited to the lung, where they may be expanded by 
perivascular  FcR-  DC. 
This model applies only to the pulmonary handling of 
soluble antigen. In other experiments, we have demonstrated 
that particulate antigens are rapidly ingested by macrophages 
and sequestered  away from pulmonary DC (manuscript in 
preparation). Thus, the lung may use distinct cellular mech- 
anisms  in its handling of inhaled antigens. 
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